We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
No fiscal-year history available for this company yet.
No P/E, the company is not profitable on a trailing basis.
Maitreya Medicare Ltd. is a healthcare provider operating a 125-bed multi-specialty hospital, Maitreya Multi-Specialty Hospital, in Surat, Gujarat. The company specializes in tertiary care, offering a broad spectrum of medical services across over 18 specialties and super-specialties. Key services include cardiology, oncology, critical care, urology, laparoscopic surgery, neurosurgery, spine surgery, nephrology, gastroenterology, and orthopedic surgery. It also provides emergency services, pathological services, and an in-house pharmacy. Maitreya Medicare primarily serves the healthcare needs of South Gujarat, positioning itself as a tertiary care referral center in the Surat region, aiming to provide affordable healthcare services. The company operates an asset-heavy model, generating revenue mainly through in-patient department services, supplemented by out-patient department services, diagnostic tests, and pharmacy sales. Recent expansion includes services in preventive, rehabilitative, elderly care, and IVF through its subsidiary, Tulip Health Check.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save MAITREYA.NS and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
